Navigating the Transition to RNA-Based Influenza Vaccines: A State-of-the-Art Review. [PDF]
Panagiotopoulos AP +7 more
europepmc +1 more source
Development of mRNA vaccines against herpes zoster. [PDF]
Li D +9 more
europepmc +1 more source
Cutaneous Events After Recombinant Zoster Vaccination and Shoulder Injury Related to Zoster Vaccine Administration: A Narrative Review. [PDF]
Ciccullo C +10 more
europepmc +1 more source
Re-entering the cell: Is the intracellular space the true therapeutic niche for aptamers? [PDF]
Giangrande PH.
europepmc +1 more source
mRNA-1010 and the Future of Seasonal Influenza Prevention: Towards Next-Generation Respiratory Vaccination. [PDF]
Panagiotopoulos AP +4 more
europepmc +1 more source
Long-term Immunogenicity and Safety Profile of the Adjuvanted RSVPreF3 Vaccine in Korean Older Adults: A Sub-analysis of a Phase 3 Trial. [PDF]
Park SB +8 more
europepmc +1 more source
Editorial: Non-reactogenic vaccines against Q-fever
Anthony E. Gregory, D. Huw Davies
openaire +3 more sources
Immunogenicity and Safety of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine When Co-administered With the Adjuvanted Recombinant Herpes Zoster Subunit Vaccine in Adults ≥ 50 Years of Age. [PDF]
Roussy JF +14 more
europepmc +1 more source
The reactogenicity of rubella vaccine in a population of United Kingdom schoolgirls
M, Poyner +3 more
openaire +2 more sources
Immunogenicity and Safety of Coadministration of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine and a COVID-19 mRNA Vaccine in Adult s Aged ≥50 Years: A Phase 3, Randomized, Noninferiority Trial. [PDF]
Bonten M +13 more
europepmc +1 more source

